New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 10, 2026

Mar. 10, 2026

SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

GlobeNewswire

Mar. 10, 2026

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

GlobeNewswire

Mar. 10, 2026

Nominations Now Open for PerfectServe’s Sixth Annual Nurses of Note Awards Program

GlobeNewswire

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire

Mar. 10, 2026

VIVUS tillkännager prissänkning för QSIVA® i Norden och Polen

GlobeNewswire

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire

Mar. 10, 2026

VIVUS laskee QSIVA®-kapselien hintaa Pohjoismaissa ja Puolassa

GlobeNewswire

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire

Mar. 10, 2026

VIVUS meddeler QSIVA® prisreduktion i de nordiske lande og Polen

GlobeNewswire

Mar. 10, 2026

Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

GlobeNewswire

Mar. 10, 2026

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire

Mar. 10, 2026

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

GlobeNewswire

Mar. 10, 2026

HealthEdge HealthRules® Payer Works with AWS to Set a New Scalability Benchmark, Expanding to Support Health Plans with More Than 40 Million Members

GlobeNewswire

Mar. 10, 2026

Imprivata Introduces Agentic Identity Management to Secure and Govern AI Agents in Healthcare

GlobeNewswire

Mar. 10, 2026

Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data with ZORYVE® (roflumilast) Cream 0.05% for Treatment of Mild-to-Moderate Atopic Dermatitis in Children Ages 2–5 in Pediatric Dermatology

GlobeNewswire

Mar. 10, 2026

Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection

GlobeNewswire

Mar. 10, 2026

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

GlobeNewswire

Mar. 10, 2026

Longeveron Announces Private Placement of up to $30 Million

GlobeNewswire

Mar. 10, 2026

Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

GlobeNewswire